Welcome to Tip’d, a social media site for finance, investing, and business topics. Want to participate? » Join Tip’d now! or read our FAQ.
Drug giant Pfizer Inc. has reached an $894 million deal to end most of the lawsuits over its two prescription pain relievers, the popular Celebrex and a similar drug, Bextra, no longer on the market.
Save & Share
Spam? Topple this!
Save & Share
Spam? Topple this!

Comments
Want to leave a comment on this story? Login or join Tip'd to comment.